Ads
related to: therapy notes pricing
Search results
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks via Yahoo Finance· 4 hours agoEditas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies...
Online Therapy vs. In-Person: What You Should Know
CNET· 3 days agoMore and more people are reaching for therapy services, and in 2024, we have online therapy options as well as in-person services to bridge some of the...
Actinium Pharmaceuticals (NYSEAMERICAN:ATNM) Earns Buy Rating from HC Wainwright
ETF DAILY NEWS· 4 hours agoActinium Pharmaceuticals (NYSEAMERICAN:ATNM – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a research report issued on Monday, Benzinga ...
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Buy Rating from HC Wainwright
ETF DAILY NEWS· 6 days agoHC Wainwright’s target price suggests a potential upside of 138.32% from the company’s current price. William Blair restated an “outperform” rating and ...
The 8 best online therapy services for teens, according to mental health experts | Fortune...
Fortune· 5 days agoOur team of mental health experts meticulously evaluated each therapy platform on our list assessing...
Citi maintains Buy rating on Cabaletta Bio post-EULAR data By Investing.com
Investing.com· 6 hours agoOn Monday, Citi reaffirmed its positive stance on Cabaletta Bio Inc . The endorsement follows the...
Health Care Roundup: Market Talk
The Wall Street Journal· 4 days agoAnalysts at Mizuho and William Blair say ...research report. They initiate coverage of the stock with a buy rating and a target price of INR2,650.00. The...
Pfizer’s gene-therapy trial failure boosts Sarepta’s stock
Market Watch· 4 days agogained 4% premarket on Thursday after a potential competitor to its gene therapy stumbled in a...
HCA Healthcare (NYSE:HCA) Hits New 52-Week High at $340.45
ETF DAILY NEWS· 5 days agoWells Fargo & Company raised their target price on shares of HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note ...
Willner & Heller LLC Takes Position in Abbott Laboratories (NYSE:ABT)
ETF DAILY NEWS· 5 hours agoWillner & Heller LLC purchased a new stake in Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund purchased 6,023 shares of the healthcare ...
Ads
related to: therapy notes pricing
